[go: up one dir, main page]

MX2022012824A - Metodos para enriquecer vesiculas extracelulares de muestras de liquido biologico. - Google Patents

Metodos para enriquecer vesiculas extracelulares de muestras de liquido biologico.

Info

Publication number
MX2022012824A
MX2022012824A MX2022012824A MX2022012824A MX2022012824A MX 2022012824 A MX2022012824 A MX 2022012824A MX 2022012824 A MX2022012824 A MX 2022012824A MX 2022012824 A MX2022012824 A MX 2022012824A MX 2022012824 A MX2022012824 A MX 2022012824A
Authority
MX
Mexico
Prior art keywords
biological fluid
fluid samples
extracellular vesicles
methods
enriching extracellular
Prior art date
Application number
MX2022012824A
Other languages
English (en)
Inventor
Christopher J Lowe
Vicki Plaks
Jane M Ruppel
Rebecca Suttmann
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2022012824A publication Critical patent/MX2022012824A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5758—
    • G01N33/57585—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invención proporciona métodos para enriquecer vesículas extracelulares (EV), que incluyen exosomas, de muestras de líquido biológico de sujetos y, opcionalmente, para realizar pruebas posteriores de las EV para identificar la presencia de biomarcadores específicos.
MX2022012824A 2020-04-17 2021-04-16 Metodos para enriquecer vesiculas extracelulares de muestras de liquido biologico. MX2022012824A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063011583P 2020-04-17 2020-04-17
PCT/US2021/027627 WO2021211935A1 (en) 2020-04-17 2021-04-16 Methods for enriching extracellular vesicles from biological fluid samples

Publications (1)

Publication Number Publication Date
MX2022012824A true MX2022012824A (es) 2022-11-07

Family

ID=75919381

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022012824A MX2022012824A (es) 2020-04-17 2021-04-16 Metodos para enriquecer vesiculas extracelulares de muestras de liquido biologico.

Country Status (13)

Country Link
US (1) US20230204588A1 (es)
EP (1) EP4136451A1 (es)
JP (1) JP2023522003A (es)
KR (1) KR20230004496A (es)
CN (1) CN115427810A (es)
AR (1) AR122422A1 (es)
AU (1) AU2021257455A1 (es)
BR (1) BR112022020884A2 (es)
CA (1) CA3178835A1 (es)
IL (1) IL297284A (es)
MX (1) MX2022012824A (es)
TW (1) TW202204896A (es)
WO (1) WO2021211935A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114073865B (zh) * 2022-01-17 2022-11-25 深圳市达科为生物工程有限公司 去除血清中外泌体的方法及过滤装置
EP4505178A1 (en) * 2022-04-07 2025-02-12 The Regents of The University of Michigan Methods and devices for screening extracellular vesicles
WO2024206493A1 (en) * 2023-03-27 2024-10-03 The General Hospital Corporation Molecular analysis of extracellular vesicles (evs) for the detection of idiopathic pulmonary fibrosis
KR20240154736A (ko) * 2023-04-18 2024-10-28 가톨릭대학교 산학협력단 면역관문 억제제의 표적화된 전달을 위한 세포외소포체의 용도
KR20240159543A (ko) * 2023-04-28 2024-11-05 연세대학교 산학협력단 유방암 유래 엑소좀 또는 세포외 소포체 분리 방법
WO2024249948A1 (en) * 2023-05-31 2024-12-05 Mayo Foundation For Medical Education And Research Methods and materials for assessing and treating cancer
CN117153252B (zh) * 2023-08-31 2024-08-16 山东第一医科大学附属省立医院(山东省立医院) 一种用于弥漫大b细胞淋巴瘤患者预后生物标志物及其系统和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012220872A1 (en) * 2011-02-22 2013-09-12 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers
WO2013049636A1 (en) * 2011-09-30 2013-04-04 The Regents Of The University Of Michigan System for detecting rare cells
CN105723221B (zh) * 2013-11-06 2018-07-06 Jsr株式会社 分离方法、检测方法、信号测定方法、疾病的判定方法、疾病治疗药的药效评价方法、试剂盒以及液态组合物
US10874610B2 (en) * 2016-10-19 2020-12-29 Northwestern University Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer
IL270864B2 (en) * 2017-05-24 2025-01-01 Nanosomix Inc Identification of biomarkers on vesicles for diagnosis and prognosis of diseases and disorders
US12404554B2 (en) * 2017-06-21 2025-09-02 Exosomics S.p.A. Methods and kits relating to the capture of CA-IX positive exosomes
EP3652315A4 (en) * 2017-07-12 2021-09-01 Exosome Diagnostics, Inc. METHODS FOR ISOLATION AND ENRICHMENT OF EXTRACELLULAR VESICLE POPULATIONS DERIVED FROM BIOFLUIDS, AND ASSOCIATED METHODS OF USE
US20190324023A1 (en) * 2018-04-20 2019-10-24 Imra America, Inc. Detection of extracellular vesicles using nanoparticles

Also Published As

Publication number Publication date
CA3178835A1 (en) 2021-10-21
IL297284A (en) 2022-12-01
WO2021211935A1 (en) 2021-10-21
TW202204896A (zh) 2022-02-01
AR122422A1 (es) 2022-09-07
BR112022020884A2 (pt) 2022-11-29
CN115427810A (zh) 2022-12-02
KR20230004496A (ko) 2023-01-06
JP2023522003A (ja) 2023-05-26
AU2021257455A1 (en) 2022-10-20
US20230204588A1 (en) 2023-06-29
EP4136451A1 (en) 2023-02-22

Similar Documents

Publication Publication Date Title
MX2022012824A (es) Metodos para enriquecer vesiculas extracelulares de muestras de liquido biologico.
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
NZ749272A (en) Phospholipid ether analogs for the identification and isolation of circulating tumor cells
BR112018009071A8 (pt) método para preparar uma amostra, composição homogenizada, métodos para gerar dados, para tratar uma doença, de identificação de um marcador, para determinar o prognóstico de um câncer, para determinar um perfil fenotípico, para armazenar a composição homogenizada, para preparar uma amostra de tecido e preparar a composição homogenizada
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
EP3907509A3 (en) Diagnosis of early stage pancreatic cancer
CL2019003286A1 (es) Ensayos de diagnóstico para detectar, cuantificar y/o rastrear microbios y otros analitos.
BR112017025097A2 (pt) método para quantificação espectrométrica de massa de analitos extraídos de um dispositivo de microamostragem
MX2020009278A (es) Ensayos para detectar la neurodegeneración.
MX2015012437A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
MX383381B (es) Métodos y composiciones para detectar proteínas mal plegadas.
GB201207297D0 (en) Analytical methods and arrays for use in the same
BR112019005167A2 (pt) método e kit para analisar uma amostra
MX2017009485A (es) Detección y aislamiento de células fetales basadas en microfluidos para prueba prenatal no invasiva.
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
BR112016024730A2 (pt) dispositivo, método e conjunto de análise imunocromatográfica
UY37757A (es) Composiciones, procedimientos y/o kits que comprenden un dominio extracelular de cd38 humano recombinante
MX377026B (es) Biomarcadores para la progresión de enfermedades en melanoma.
BR112019005172A2 (pt) método e kit para analisar uma amostra
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente
BR112017011026A2 (pt) métodos analíticos e arranjos para uso nos mesmos
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
AR071034A1 (es) Uso de la catepsina c en el diagnostico de susceptibilidad al dolor y para el tratamiento del dolor
BR112015025255A2 (pt) métodos e arranjos para uso no mesmo
MX2019000591A (es) Tira mejorada de ensayo de analisis de orina de bajo volumen de muestra, kits analiticos y metodos de uso relacionados con la misma.